Alteration ofN-glycan profiles in patients with chronic hepatitis and hepatocellular carcinoma-Reference-Cited by-同舟云学术

Alteration ofN-glycan profiles in patients with chronic hepatitis and hepatocellular carcinoma

Published:2015-01-13 Issue:9 Volume:45 Page:986-993
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Miyahara Koji¹,Nouso Kazuhiro¹²,Dohi Chihiro¹,Morimoto Yuki¹,Kinugasa Hideaki¹,Wada Nozomu¹,Takeuchi Yasuto¹,Kuwaki Kenji¹,Onishi Hideki¹²,Ikeda Fusao¹²,Miyake Yasuhiro¹,Nakamura Shinichiro¹,Shiraha Hidenori¹,Takaki Akinobu¹,Amano Maho³⁴,Nishimura Shin-Ichiro³⁴,Yamamoto Kazuhide¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

2. Department of Molecular Hepatology; Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences; Okayama Japan

3. Field of Drug Discovery Research; Faculty of Advanced Life Science and Graduate School of Life Science; Hokkaido University; Sapporo Japan

4. Medicinal Chemistry Pharmaceuticals; Sapporo Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12441/fullpdf

Reference32 articles.

1. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens;Shafritz;N Engl J Med,1981

2. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus;Kiyosawa;Hepatology,1990

3. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy;Yoshida;Ann Intern Med,1999

4. Recent advances in the treatment of hepatocellular carcinoma;Padhya;Curr Opin Gastroenterol,2013

5. Alteration of protein glycosylation in liver diseases;Blomme;J Hepatol,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma;Alimentary Pharmacology & Therapeutics;2023-10-25

2. N-glycosylation by N-acetylglucosaminyltransferase IVa enhances the interaction of integrin β1 with vimentin and promotes hepatocellular carcinoma cell motility;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2023-10

3. Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood;International Journal of Molecular Sciences;2022-04-23

4. Clinical utility of a serum glycome analysis in patients with colorectal cancer;Journal of Gastroenterology and Hepatology;2022-02-16

5. ANALYSIS OF CARBOHYDRATES AND GLYCOCONJUGATES BY MATRIX‐ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY: AN UPDATE FOR 2015–2016;Mass Spectrometry Reviews;2021-03-16